Sp-cAMPS
Sp-cAMPS, a cAMP analog, is potent activator of cAMP-dependent PKA I and PKA II. Sp-cAMPS is also a potent, competitive phosphodiesterase (PDE3A) inhibitor with a Ki of 47.6 µM. Sp-cAMPS binds the PDE10 GAF domain with an EC50 of 40 μM.
For research use only. We do not sell to patients.
- CAS No.: 71774-13-5
- Formula: C10H12N5O5PS
- Molecular Weight:345.27
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
-
HY-12306
8-Bromo-cAMP sodium saltPKA Activator -
HY-111673
8-CPT-Cyclic AMP sodiumPKA Activator -
HY-15979
H-89PKA Inhibitor -
HY-15979A
H-89 dihydrochloridePKA Inhibitor -
HY-B1898
MetadoxinePKA Inhibitor -
HY-B0764A
Bucladesine hemicalciumApoptosis Inducer -
HY-100530D
Rp-cAMPS sodium saltPKA I/II Antagonist -
HY-N6789
KT5720PKA Inhibitor -
HY-111759
JaspamycinPKA Activator -
HY-110218
CW 008CREB/PKA Agonist -
HY-B0764
Bucladesine sodiumcAMP Analog -
HY-103322
6-Bnz-cAMP sodium saltPKA Activator
Biological Activity
Description
|
PKA I |
PKA II |
PDE3A 47.6 μM (Ki) |
PDE10 GAF domain 50 μM (EC50) |
In Vitro
Treatment of hepatocytes with Sp-cAMPS, the stimulatory diastereomer of adenosine cyclic 3',5'-phosphorothioate, mimics the response seen with glucagon. The glucagon-stimulated increases in the level of Ca2+ can be mimicked by Sp-cAMPS[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. .
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 71774-13-5
-
Molecular Weight 345.27
-
Formula C10H12N5O5PS
-
SMILES
O[C@H]1[C@@H](O[C@@]2([H])[C@@]1([H])O[P@](OC2)(S)=O)N3C4=C(C(N)=NC=N4)N=C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Su H Hung, et al. A new nonhydrolyzable reactive cAMP analog, (Sp)-adenosine-3',5'-cyclic-S-(4-bromo-2,3-dioxobutyl)monophosphorothioate irreversibly inactivates human platelet cGMP-inhibited cAMP phosphodiesterase. Bioorg Chem. 2002 Feb;30(1):16-31. [Content Brief]
[2]. L Y Wang, et al. Regulation of kainate receptors by cAMP-dependent protein kinase and phosphatases. Science. 1991 Sep 6;253(5024):1132-5. [Content Brief]
[3]. Ronald Jäger, et al. Activation of PDE10 and PDE11 phosphodiesterases. J Biol Chem. 2012 Jan 6;287(2):1210-9. [Content Brief]
[4]. P A Connelly,et al. A study of the mechanism of glucagon-induced protein phosphorylation in isolated rat hepatocytes using (Sp)-cAMPS and (Rp)-cAMPS, the stimulatory and inhibitory diastereomers of adenosine cyclic 3',5'-phosphorothioate. J Biol Chem. 1987 Mar 25;262(9):4324-32. [Content Brief]
[5]. G Dominguez, et al. Rescuing prefrontal cAMP-CREB pathway reverses working memory deficits during withdrawal from prolonged alcohol exposure. Brain Struct Funct. 2016 Mar;221(2):865-77. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Sp-cAMPS Related Classifications
HY-100530B Related Classifications
Powered by Bioz